5/1/2025

The mega cap growth trade stalled as the chaotic introduction of tariffs accompanied by fears of a slowing U.S. economy and higher inflation. Read more here.

Source: SeekingAlpha

4/28/2025

The S&P 500 Index declined 4.27% while the benchmark Russell 1000 Growth Index (RLG) fell 9.97%. Click here to read more.

Source: SeekingAlpha

4/27/2025

The S&P 500 Index declined 4.27% while the benchmark Russell 1000 Growth Index (RLG) fell 9.97%, trailing its value counterpart by over 1,200 basis points.

Source: SeekingAlpha

4/25/2025

GENEVA, April 25, 2025--Alcon Elevates Vitreoretinal and Cataract Surgery for Superior Efficiency* with UNITY VCS and UNITY CS

Source: Yahoo

4/13/2025

The ClearBridge Large Cap Growth ESG Strategy outperformed its Russell 1000 Growth Index benchmark in the first quarter. Read more here.

Source: SeekingAlpha

4/11/2025

Harding Loevner International Equity composite gained 5.2% (gross) for Q1 2025, nearly matching the 5.4% gain of the MSCI ACWI ex US Index. Click here to read the full commentary.

Source: SeekingAlpha

4/10/2025

Source: SeekingAlpha

4/9/2025

Source: SeekingAlpha

4/8/2025

ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Growth Strategy” first quarter 2025 investor letter. A copy of the letter can be downloaded here. The majority of growth indexes entered correction territory during the quarter, due to pressure from the chaotic tariff implementation, concerns about a weakening U.S. economy, and increased inflation. […]

Source: Yahoo

4/7/2025

The ClearBridge Large Cap Growth Strategy outperformed its Russell 1000 Growth Index benchmark in Q1 2025. Click here to read the full letter.

Source: SeekingAlpha

4/4/2025

GENEVA, April 04, 2025--Alcon Publishes Agenda for 2025 Annual General Meeting

Source: Yahoo

4/3/2025

Alcon introduces Clareon PanOptix Pro IOL to select practices across the United States, with commercial availability expected in May.

Source: Yahoo

4/2/2025

GENEVA, April 02, 2025--Alcon Expands Leadership in IOL Innovation with Clareon PanOptix Pro, Delivering Best-in-Class Light Utilization and Less Light Scatter

Source: Yahoo

4/1/2025

Alcon, Glaukos and Regeneron Pharmaceuticals are part of the Zacks top Analyst Blog.

Source: Yahoo

4/1/2025

Impax Global Opportunities Fund underperformed the benchmark during the last quarter. Its overweight position in Health Care was a relative headwind. Read more here.

Source: SeekingAlpha

3/28/2025

Alcon (ALC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Source: Yahoo

3/27/2025

The share acquisition is the latest twist in a dispute between Alcon and fellow Aurion shareholder Deerfield Management over the direction of the company, which filed to go public in January.

Source: Yahoo

3/26/2025

International equities declined in the fourth quarter of 2024 in US-dollar terms, in part due to the strength of the US dollar. Read more here.

Source: SeekingAlpha

3/26/2025

GENEVA, March 26, 2025--Alcon Acquires Majority Interest in Aurion Biotech, Inc. to Advance Innovative Cell Therapy for Corneal Endothelial Disease

Source: Yahoo

3/25/2025

A Relative Strength Rating upgrade for Alcon shows improving technical performance. Will it continue?

Source: Yahoo